Type 2 deiodinase expression is induced by peroxisomal proliferator- activated receptor-γ agonists in skeletal myocytes

Endocrinology

Volumn 150, Issue 4, 2009, Pages 1976-1983

  Grozovsky, Renata ^a   Ribich, Scott ^a   Rosene, Matthew L ^a   Mulcahey, Michelle A ^b   Huang, Stephen A ^b   Patti, Mary Elizabeth ^c   Bianco, Antonio C ^a   Kim, Brian W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEIODINASE 2; INSULIN; LIOTHYRONINE; LITHOCHOLIC ACID; MUSCLE PROTEIN; OXIDOREDUCTASE; PIOGLITAZONE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE HOMOGENATE; WILD TYPE;

ANIMALS; CELLS, CULTURED; CHROMANS; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; INSULIN; IODIDE PEROXIDASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MYOBLASTS; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLIDINEDIONES;

EID: 63849337003     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0938     Document Type: Article

References (49)

1. Larsen PR, Silva JE, Kaplan MM 1981 Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev 2:87-102
2. St. Germain DL, Galton VA 1997 The deiodinase family of selenoproteins. Thyroid 7:655-668
3. Kuiper GG, Kester MH, Peeters RP, Visser TJ 2005 Biochemical mechanisms of thyroid hormone deiodination. Thyroid 15:787-798
4. Kaplan MM, Pan C, Gordon PR, Lee JK, Gilchrest BA 1988 Human epidermal keratinocytes in culture convert thyroxine to 3,5,3'-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin. J Clin Endocrinol Metab 66:815-822
5. Santini F, Vitti P, Chiovato L, Ceccarini G, Macchia M, Montanelli L, Gatti G, Rosellini V, Mammoli C, Martino E, Chopra IJ, Safer JD, Braverman LE, Pinchera A 2003 Role for inner ring deiodination preventing transcutaneous passage of thyroxine. J Clin Endocrinol Metab 88:2825-2830
6. Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR 2003 Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 88:1384 -1388
7. Wasco EC, Martinez E, Grant KS, St. Germain EA, St. Germain DL, Galton VA 2003 Determinants of iodothyronine deiodinase activities in rodent uterus. Endocrinology 144:4253-4261
8. Galton VA 2005 The roles of the iodothyronine deiodinases in mammalian development. Thyroid 15:823-834
9. Bianco AC, Kim BW 2006 Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 116:2571-2579
10. Silva JE, Larsen PR 1983 Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature 305:712-713
11. Bianco AC, Silva JE 1988 Cold exposure rapidly induces virtual saturation of brown adipose tissue nuclear T3 receptors. Am J Physiol 255:E496 -E503
12. Bianco AC, Sheng X, Silva JE 1988 Cold exposure rapidly induces virtual saturation of brown adipose tissue nuclear T3 receptors. J Biol Chem 263: 18168 -18175
13. Bianco AC, Silva JE 1987 Intracellular conversion of thyroxine to triiodothy- ronine is required for the optimal thermogenic function of brown adipose tissue. J Clin Invest 79:295-300
14. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, AuwerxJ2006Bile acids induce energyexpenditure bypromoting intracellular thyroid hormone activation. Nature 439:484 -489
15. Salvatore D, Bartha T, Harney JW, Larsen PR 1996 Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308 -3315
16. Mebis L, Langouche L, Visser TJ, Van den Berghe G 2007 The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab 92:3330 -3333
17. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC, Maia AL 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-3478
18. Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da-Silva WS, Harney J, Engel FB, Obregon MJ, Larsen PR, Bianco AC, Huang SA 2008 Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118:975-983
19. da-Silva WS, HarneyJW, Kim BW, LiJ, Bianco SD, Crescenzi A, Christoffolete MA, Huang SA, Bianco AC 2007 The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation. Diabetes 56:767-776
20. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, Mori M 1999 J Clin Endocrinol Metab 84:3293-3300
21. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St. Germain DL, Galton VA 2001 Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15:2137-2148
22. de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim S-W, Harney JW, Larsen PR, Bianco AC 2001 The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108:1379 -1385
23. Christoffolete MA, Linardi CCG, de Jesus LA, Ebina KN, Carvalho SD, Ribeiro MO, Rabelo R, Curcio C, Martins L, Kimura ET, Bianco AC 2004 Mice with targeted disruption of the Dio2 gene have cold-induced overex- pression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes 53:577-584
24. Forrest D, Ng L, Kelley M, Schneider MJ, St. Germain DL, Galton VA Cochlear defects and deafness in mice lacking type II selenodeiodinase. Proc 73rd Annual Meeting of the American Thyroid Association, Washington, DC, 2001 (Abstract P4)
25. Rando TA, Blau HM 1994 Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125: 1275-1287
26. 3 in euthyroid humans. J Clin Invest 115:2524 -2533
27. Croteau W, Bodwell JE, Richardson JM, St. Germain DL 1998 Conserved cysteines in the type 1 deiodinase selenoprotein are not essential for catalytic activity. J Biol Chem 273:25230 -25236
28. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M 2003 A G protein-coupled receptor responsive to bile acids. J Biol Chem 278:9435-9440
29. Zurlo F, Larson K, Bogardus C, Ravussin E 1990 Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86:1423-1427
30. al-Adsani H, Hoffer LJ, Silva JE 1997 Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 82:1118 -1125
31. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, PollinTI, PoehlmanET, Shuldiner AR, Celi FS 2002 Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence ofinteraction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 51: 880-883
32. Mentuccia D, Thomas MJ, Coppotelli G, Reinhart L, Mitchell BD, Shuldiner AR, Celi FS, The Thr92Ala deiodinase type 2(DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish. Program of the 86th Annual Meeting of The Endocrine Society, New Orleans, LA, 2004 (Abstract P3-382)
33. Grarup N, Andersen MK, Andreasen CH, Albrechtsen A, Borch-Johnsen K, Jorgensen T, Auwerx J, Schmitz O, Hansen T, Pedersen O 2007 Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. J Clin Endocrinol Metab 92:363-366
34. Fiorito M, Torrente I, De Cosmo S, Guida V, Colosimo A, Prudente S, Flex E, Menghini R, Miccoli R, Penno G, Pellegrini F, Tassi V, Federici M, Trischitta V, Dallapiccola B 2007 Interaction of DIO2 T92A and PPARγ2 P12A polymorphisms in the modulation of metabolic syndrome. Obesity (Silver Spring) 15:2889 -2895
35. Silva JE 1995 Thyroid hormone control of thermogenesis and energy balance. Thyroid 5:481-492
36. Lebon V, Dufour S, Petersen KF, Ren J, Jucker BM, Slezak LA, Cline GW, Rothman DL, Shulman GI 2001 Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest 108:733-737
37. Reitman ML, He Y, Gong DW 1999 Thyroid hormone and other regulators of uncoupling proteins. Int J Obes Relat Metab Disord 23(Suppl 6):S56 -S59
38. Harper ME, Seifert EL 2008 Thyroid hormone effects on mitochondrial energetics. Thyroid 18:145-156
39. Dillmann WH 2002 Cellular action of thyroid hormone on the heart. Thyroid 12:447-452
40. Reis M, Farage M, de Meis L 2002 Thermogenesis and energy expenditure: control of heat production by the Ca(2 + )-ATPase of fast and slow muscle. Mol Membr Biol 19:301-310
41. Mills I, Barge RM, Silva JE, Larsen PR 1987 Insulin stimulation of iodothyronine 5' -deiodinase in rat brown adipocytes. Biochem Biophys Res Commun 143:81-86
42. CzechMP, MalbonCC, KermanK, Gitomer W, PilchPF 1980 Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle. J Clin Invest 66:574 -582
43. WuP 2007 Thyroid disorders and diabetes. It is common for a person to be affected by both thyroid disease and diabetes. Diabetes Self Manag 24:80 -82, 85-87
44. Gouveia CH, Christoffolete MA, Zaitune CR, Dora JM, HarneyJW, Maia AL, Bianco AC 2005 Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology 146:195-200
45. Mizuma H, Murakami M, Mori M 2001 Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res 88:313-318
46. Maeda A, Toyoda N, Yasuzawa-Amano S, Iwasaka T, Nishikawa M 2003 Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells. Mol Cell Endocrinol 200:111-117
47. Huang SA, Mulcahey MA, Crescenzi A, Chung M, Kim B, Barnes CA, Kuijt W, Tu HM, Harney JW, Larsen PR 2005 Transforming growth factor-β promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol Endocrinol 19:3126 -3136
48. Brown DD 2005 The role of deiodinases in amphibian metamorphosis. Thyroid 15:815-821
49. Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, Zavacki AM, Fenzi G, Grachtchouk M, Hutchin M, Dlugosz AA, Bianco AC, Missero C, Larsen PR, Salvatore D 2007 Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA 104:14466-14471